Showing 1 - 2 results of 2 for search 'Rolando Vallansot', query time: 0.02s Refine Results
  1. 1
    Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients

    Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients by Natalia Estrada, Blanca Xicoy, Fabian Beier, Olga Garcia, Cristian Morales, Concepción Boqué, Miguel Sagüés, Mónica S. Ventura Ferreira, Rolando Vallansot, Sílvia Marcé, Marta Cabezón, Tim H. Brümmendorf, Lurdes Zamora

    Published 2021-12-01
    Get full text
    Article
  2. 2
    S153: MECHANISMS OF TROMBOGENESIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDER TREATMENT WITH PONATINIB AND OTHER TYROSINE KINASE INHIBITORS

    S153: MECHANISMS OF TROMBOGENESIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDER TREATMENT WITH PONATINIB AND OTHER TYROSINE KINASE INHIBITORS by Ernesto José Cuenca Zamora, Sonia Águila, María José Lis, Maria Carmen Garcia Hernandez, María Jose Fernández, María Soledad Noya Pereira, Elvira Mora Castera, Luis Palomera Bernal, Maria Alicia Senin Magan, Raúl Pérez López, Manuel Perez Encinas, Anna Angona Figueras, José Manuel Puerta, Rolando Vallansot, Venancio Conesa Garcia, Juan Carlos Hernandez-Boluda, Ana Rosell Mas, Montserrat Cortés, Guillermo Ortí, Blanca Xicoy Cirici, Gonzalo Carreño Gomez-Tarragona, Pilar Giraldo, Maria L Lozano, Valentin Garcia Gutierrez, Francisca Ferrer-Marín, On Behalf of Spanish Group of Chronic Myeloid Leukemia (Gelmc)

    Published 2023-08-01
    Get full text
    Article

Search Tools: